cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25934/00003280
title: A Phase 1, Randomized, Open-Label, Single Center, Multiple Dose, Four Period, Three-Way Crossover Study to Determine the Bioavailability and Assess the Intragastric pH Effects of Dexlansoprazole Delayed Release Orally Disintegrating Tablets Formulations [Formulation A (30 mg) and Formulation B (30 mg)] to Dexlansoprazole Delayed Release Capsule (30 mg) in Healthy Subjects 

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002736
title: A Randomized, Open-Label Study to Assess the Pharmacokinetics of a TAK-375 (Ramelteon) Tablet for Sublingual Administration and its Bioavailability Relative to Approved Ramelteon Tablets in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002734
title: A Randomized, Double-Blind Placebo-Controlled, Ascending Single-Dose, Safety, Tolerance and Pharmacokinetic Study of Five Doses of TAK-375 in Healthy Adult Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002731
title: An Open-Label Study to Assess the Pharmacokinetic Drug-Drug Interaction Between Ramelteon and Lorazepam in Normal Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002732
title: The Effect of Ramelteon (TAK-375) on the Pharmacokinetics and Pharmacodynamics of Ethinyl Estradiol (30 μg) and Levonorgestrel (150 μg) [Microgynon 30®], in Healthy Adult Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003332
title: A Study to Investigate the Residual Effects of Ramelteon (8 mg), Zopiclone (7.5 mg) and Placebo on Actual Driving, Memory, Psychomotor Performance and Mood

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002729
title: TAK-375 - A Phase I, Open-Label, Randomised, Balanced, Two-Period Crossover Study to Investigate the Absolute Bioavailability of a Single Oral Dose in Healthy Male Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002728
title: A Phase I, Randomised, Double-Blind, Placebo-Controlled, Ascending, Multiple Oral Dose Pharmacokinetic, Safety, Tolerability and Pharmacodynamic Study of TAK-375 in Healthy Adult Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002727
title: A Phase 3, Single Dose Study of TAK-375 in Healthy Adult Male Subjects - To Determine the Pharmacokinetic Profiles of a Finished Formulation

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002725
title: Effect of Age on the Pharmacokinetics of a Single Dose of TAK-375 in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002724
title: Placebo-Controlled Double-Blind 3-Way Crossover Study on TAK-375 in Healthy Middle Aged Male Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002720
title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Outpatient, Efficacy and Safety Study of TAK-375 in Adults and Elderly Adults with Chronic Insomnia

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.5281/zenodo.14216482
title: Adult Income Dataset

description:  A widely cited KNN dataset used as a playground. It focuses on predicting whether an individual's annual income is above or below $50,000 based on various attributes like education, age, gender, and occupation.
DOI: 10.5281/zenodo.14217100
title: Adult Income Dataset

description:  A widely cited KNN dataset used as a playground. It focuses on predicting whether an individual's annual income is above or below $50,000 based on various attributes like education, age, gender, and occupation.
DOI: 10.5281/zenodo.14218316
title: Adult Income Dataset

description:  A widely cited KNN dataset used as a playground. It focuses on predicting whether an individual's annual income is above or below $50,000 based on various attributes like education, age, gender, and occupation.
DOI: 10.5281/zenodo.14216481
title: Adult Income Dataset

description:  A widely cited KNN dataset used as a playground. It focuses on predicting whether an individual's annual income is above or below $50,000 based on various attributes like education, age, gender, and occupation.

Dataset derived from 1994 US Census data. Cleaned and processed by Huda Basharat. The dataset contains demographic and income-related information. It was curated for research on income classification based on age, education, occupation, and other socio-economic factors.

Usage Guidelines:This dataset is intended for academic research and is not suitable for commercial use. Users must properly cite the dataset when using it in research or publications.

Citation: Huda Basharat (2024). Adult Income Dataset. Zenodo. DOI: 10.528/zenodo.14216482.
DOI: 10.5281/zenodo.14223441
title: Adult Income Dataset

description:  A widely cited KNN dataset used as a playground. It focuses on predicting whether an individual's annual income is above or below $50,000 based on various attributes like education, age, gender, and occupation.

Dataset derived from 1994 US Census data. Cleaned and processed by Huda Basharat. The dataset contains demographic and income-related information. It was curated for research on income classification based on age, education, occupation, and other socio-economic factors.

Usage Guidelines:This dataset is intended for academic research and is not suitable for commercial use. Users must properly cite the dataset when using it in research or publications.

Citation: Huda Basharat (2024). Adult Income Dataset. Zenodo. DOI: 10.528/zenodo.14216482.
DOI: 10.15468/dl.4xnp8y
title: Occurrence Download

description: A dataset containing 19 species occurrences available in GBIF matching the query:
{
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 },
 "TaxonKey is one of (Pleione forrestii Schltr.)"
 ]
}

 The dataset includes 19 records from 7 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002317-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00002719
title: An Open-Label, Parallel-Group Comparison Study of Single-Dose Pharmacokinetics of SYR-472 in Subjects With and Without Moderate Hepatic Impairment

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002939
title: An Open-Label, Parallel-Group Comparison Study of Single-Dose Pharmacokinetics of SYR-472 in Subjects With Varying Degrees of Renal Impairment and Their Healthy Matched Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.15468/dl.ry3qk8
title: Occurrence Download

description: A dataset containing 358495 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is China",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "IucnRedListCategory is LC",
 "OccurrenceStatus is Present",
 "TaxonKey is Aves",
 "Year 2000-2015"
 ]
}

 The dataset includes 358495 records from 25 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002265-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00002711
title: An Open-Label, Randomized, 4-Period Crossover Study to Determine the Bioequivalence of the Phase 3 SYR-322 Tablets (12.5 and 25 mg) and Pioglitazone (15 and 45 mg) When Administered as Individual Tablets and as Combination Products

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002710
title: An Open-Label, Randomized, 4-Period Crossover Study to Determine the Bioequivalency of the Phase 3 SYR-322 Tablets (12.5 and 25 mg) and Pioglitazone (15 and 45 mg) When Administered as Individual Tablets and as Combination Products

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002709
title: An Open-Label, Randomized, 2-Cohort, 4-Sequence, 4-Period Crossover Study to Determine the Bioequivalence of Alogliptin 6.25 mg and 12.5 mg and Glucophage (Metformin HCl) 500 mg and 1000 mg When Administered as Individual Tablets and as a Fixed-Dose Combination Tablet

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002708
title: A Phase 1, Open-Label, Randomized, Crossover Study to Determine the Effects of Food on the Pharmacokinetics of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003249
title: A Randomized, Open Label, Crossover Study to Evaluate Bioequivalence Following a Single Oral Dose Administration of a Combination Tablet of SYR-322 and Metformin Hydrochloride in Healthy Adult Male Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002706
title: An Open-Label, Randomized, 2-Period Crossover Study to Determine the Bioequivalence of SYR-32  (12.5 mg) and AD-4833 (30 mg) Tablets When Administered as Individual Tablets and as a Combination Tablet and to Determine the Effect of Food on the Pharmacokinetics of the Combination Tablet

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002704
title: A Phase 1, Open-Label, Single and Multiple-Dose Study of the Pharmacokinetics of Alogliptin 25 mg in Healthy Chinese Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002703
title: An Open-Label, Randomized, Single-Dose, 2-Period Crossover Study to Evaluate the Absolute Bioavailability of Alogliptin in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002702
title: An Open-Label, Multiple-Dose, Randomized, Crossover Study to Determine the Pharmacokinetics and Pharmacodynamics of SYR-322 Twice Daily Versus Once-Daily Dosing in Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002700
title: An Open-label, Randomized, 2-Period Crossover Study to Determine the Bioequivalency of the Phase 3 SYR-322 Tablets (12.5 and 25 mg) With the Commercial SYR-322 Tablets (12.5 and 25 mg) in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002701
title: A Phase 1, Multiple-Dose, Open-Label, Randomized, 3-Period Crossover Study to Evaluate the Effect of SYR-322 on the Pharmacokinetics of Digoxin in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002698
title: A Phase 1, Open-Label, Randomized, Multiple-Dose, Crossover Study to Assess the Drug-Drug Interaction of SYR-322 and Atorvastatin

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002699
title: An Open-Label, Randomized, Crossover Study to Determine the Effect of Food on the Pharmacokinetics of SYR-322 in Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002697
title: The Effect of SYR-322 on the Pharmacokinetics and Pharmacodynamics of Ethinyl Estradiol and Norethindrone (Ortho-Novum® 1/35) in Healthy Adult Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.